Breast Cancer

	12/17/2009	Core Needle Biopsy for Breast Cancer as Effective, Safe as Surgical Biopsy - (DGNews)
	12/16/2009	Ketorolac Tromethamine Does Not Reduce Pain, Discomfort Associated With Mammograms: Presented at SABCS - (DGDispatch)
	12/15/2009	Anthracycline-Docetaxel Chemo as Effective, but Less Toxic Than Anthracycline Polychemotherapy for Breast Cancer: Presented at SABCS - (DGDispatch)
	12/15/2009	Zoledronic Acid Improves Bone Loss Associated With Adjuvant AI Therapy in Postmenopausal Breast Cancer Patients: Presented at SABCS - (DGDispatch)
	12/15/2009	TopAbstracts in Breast Cancer 12/15/2009 - (DGNews)
	12/15/2009	Benefits of Docetaxel After FEC Regimen Sustained for 8 Years in Node-Positive Breast Cancer: Presented at SABCS - (DGDispatch)
	12/15/2009	Letrozole/Trastuzumab Superior to Letrozole Alone for Patients With Both HR+, HER2+ Metastatic Breast Cancer: Presented at SABCS - (DGDispatch)
	12/14/2009	Exemestane Therapy Show Unfavourable Changes in Lipid Profile: Presented at SABCS - (DGDispatch)
	12/14/2009	Bevacizumab Plus Docetaxel Improves Progression-Free Survival, but Not Overall Survival in Metastatic Breast Cancer: Presented at SABCS - (DGDispatch)
	12/14/2009	Adding Bevacizumab to Second-Line Chemo Improves Progression-Free Survival in Metastatic Breast Cancer: Presented at SABCS - (DGDispatch)
	12/14/2009	Switching to an Aromatase Inhibitor at Year 5 of Tamoxifen Therapy Reduces Breast Cancer Recurrence: Presented at SABCS - (DGDispatch)
	12/14/2009	Primary Tumour Resection Improves Outcomes in Advanced Breast Cancer: Presented at SABCS - (DGDispatch)
	12/14/2009	Soy food intake and breast cancer survival (JAMA)
	12/13/2009	ACE Inhibitors and ARBs May Protect Against Breast Cancer Recurrence: Presented at SABCS - (DGDispatch)
	12/13/2009	Neratinib/Paclitaxel Combination Shows Promise in Metastatic Breast Cancer: Presented at SABCS - (DGDispatch)
	12/13/2009	Long-Term Follow-Up Using PET-CT Can Help Detect Lymph Node Recurrence in Breast Cancer: Presented at SABCS - (DGDispatch)
	12/13/2009	Adjuvant Trastuzumab With Chemotherapy for 1 Year Delays Breast Cancer Progression: Presented at SABCS - (DGDispatch)
	12/12/2009	Whole Radiation Recommended for Mucinous Carcinoma: Presented at SABCS - (DGDispatch)
	12/12/2009	Docetaxel Plus Capecitabine Shows More Benefit as First-Line Therapy for Metastatic Breast Cancer Than Docetaxel Plus Epirubicin: Presented at SABCS - (DGDispatch)
	12/12/2009	No Survival Benefit for 5-FU/Docetaxel After Preoperative Epirubicin/Cyclophosphamide in Inflammatory Breast Cancer: Presented at SABCS - (DGDispatch)
	12/12/2009	Adding Bevacizumab to Second-Line Chemo Improves Progression-Free Survival in Metastatic Breast Cancer: Presented at SABCS - (DGDispatch)
	12/12/2009	Risks of Autologous Stem-Cell Transplantation Outweigh Benefits in Treating High-Risk Breast Cancer: Presented at SABCS - (DGDispatch)
	12/12/2009	Adding Lapatinib, Continuing Trastuzumab Despite Progression Adds Months to Breast Cancer Survival: Presented at SABCS - (DGDispatch)
	12/11/2009	Ibandronate Offers Pain Relief With Renal Safety in Women With Breast Cancer, Metastatic Bone Disease: Presented at SABCS - (DGDispatch)
	12/11/2009	Exemestane for 5 Years Not Superior to Tamoxifen Followed by Exemestane for Breast Cancer: Presented at SABCS - (DGDispatch)
	12/11/2009	No Cardiac Safety Problems When Casopitant Is Given With Anthracycline for Malignant Solid Tumours: Presented at SABCS - (DGDispatch)
	12/11/2009	High-Dose Fulvestrant Postpones Disease Progression in Advanced Breast Cancer: Presented at SABCS - (DGDispatch)
	12/11/2009	Lymphedema Continues to Appear Years After Breast Cancer Treatment: Presented at SABCS - (DGDispatch)
	12/11/2009	Pregnancy Does Not Worsen Outcomes Among Women With Breast Cancer: Presented at SABCS - (DGDispatch)
	12/11/2009	Optimal Duration of Neoadjuvant Letrozole Longer Than the Traditional 4 Months to Permit Breast-Conserving Surgery: Presented at SABCS - (DGDispatch)